SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has appointed veteran medical technology finance executive Sarah M. Romano as chief financial officer, effective August 3, 2026. The addition of Romano, who brings more than two decades of experience in public-company finance, capital markets, and medical technology, comes as the company continues to pursue U.S. Food and Drug Administration (FDA) clearance for its SSi Mantra surgical robotic system while expanding its international footprint.
Romano has raised more than $100 million during her career and previously served as CFO at Vicarious Surgical, another robotic surgical technology developer, where she led financial and operational initiatives to reduce cash burn and strengthen the balance sheet. Her appointment is expected to bolster SS Innovations’ financial strategy as it navigates the regulatory pathway and scales commercialization. The SSi Mantra platform, which has already been used in over 1,000 surgical procedures globally, is currently undergoing preparations for FDA review (https://nnw.fm/yY4UM).
The leadership change coincides with significant operational milestones. The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (SSICRS) cardiac robotic surgery training program, which welcomed 33 healthcare professionals from seven countries. This underscores SS Innovations’ emphasis on surgeon education alongside technology deployment, a critical component in driving adoption of robotic surgery in emerging markets.
SS Innovations has been expanding its global presence, with installations of the SSi Mantra system in India and other regions. The company’s strategy focuses on providing affordable robotic surgery solutions to address the unmet need for minimally invasive procedures worldwide. The appointment of Romano signals a commitment to financial discipline and strategic growth as the company prepares for potential FDA clearance, which would open access to the large U.S. market.
For investors, the latest updates on SSII are available in the company’s newsroom at https://nnw.fm/SSII. The combination of a seasoned CFO, progress in training programs, and regulatory momentum positions SS Innovations to capitalize on the growing demand for robotic surgery.
